Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies

Next Generation Cancer Vaccine Design - Lee Group

  • Lee Group

The Lee group develops advanced computational tools to support the design of cancer vaccines by improving epitope prediction. Inaccurate prediction can lead to vaccines that miss their targets and fail to protect patients. We use machine learning and tumour data to predict which mutations are most likely to be recognised by the immune system. Our models are designed to select both personal neoantigens and shared tumour targets, enabling personalised and off-the-shelf vaccine strategies. By making predictions more accurate and reliable, we aim to help transform computational designs into effective cancer therapies.

Our team